Product Information
RESTASIS MULTIDOSE 0.05% EYE is a brand product labeled by Allergan, Inc., priced at $112.3293 per ML under NDC 00023530105. Its NADAC has been published 476 times since May 17, 2017.
The High Outlier badge above means this manufacturer's average price in the cyclosporine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/mL
Manufacturer
Allergan, Inc.NDC
00023530105
Classification
Brand
Dosage Form
EMULSION
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
CYCLOSPORINEApproval Type
New Drug (NDA)
FDA Application
NDA050790On Market Since
11/10/2016
Pharmacological Classes
Price Statistics
The NADAC for RESTASIS MULTIDOSE 0.05% EYE has been published 476 times since May 17, 2017, and over the history we have for it it has risen 39.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $112.3293 per ML |
|---|---|
| All-time high | $112.6932 (Oct 12, 2022) |
| All-time low | $80.4772 (May 17, 2017) |
| 52-week high | $112.5043 |
| 52-week low | $112.3161 |
| Median price | $107.3279 |
| Average price | $104.1372 |
| Largest weekly change | +9.5% (Jan 9, 2019) |
| Weeks tracked | 476 |
| Tracking since | May 17, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the cyclosporine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RESTASIS MULTIDOSE 0.05% EYE?
The current National Average Drug Acquisition Cost (NADAC) for RESTASIS MULTIDOSE 0.05% EYE, manufactured by Allergan, Inc., is $112.3293 per ML (NDC 00023530105), effective Jun 24, 2026.
How has the price of RESTASIS MULTIDOSE 0.05% EYE changed over time?
Over the history we have for it, the NADAC for RESTASIS MULTIDOSE 0.05% EYE has risen 39.6%. It has been tracked across 476 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for RESTASIS MULTIDOSE 0.05% EYE?
Since May 17, 2017, the NADAC for RESTASIS MULTIDOSE 0.05% EYE has ranged from a low of $80.4772 (May 17, 2017) to a high of $112.6932 (Oct 12, 2022), with a median of $107.3279 per ML.
Are there cheaper alternatives to RESTASIS MULTIDOSE 0.05% EYE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RESTASIS MULTIDOSE 0.05% EYE, so no direct lower-cost alternative is listed.
Who manufactures RESTASIS MULTIDOSE 0.05% EYE?
RESTASIS MULTIDOSE 0.05% EYE (NDC 00023530105) is labeled by Allergan, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification